BioSpace News Archive

DUBAI, United Arab Emirates, According to Future Market Insights, the global Western Blotting Market is expected to expand at close to 6.0% CAGR during the forecast period of 2021 to 2031.

The smoke evacuation system market will garner substantial growth during the tenure of 2020-2030.

Spago Nanomedical AB has received notice from the United States Patent and Trademark Office that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D.

Helixmith, a gene therapy company based in Seoul, Korea and San Diego, CA, announced an upcoming presentation on their lead plasmid DNA product, Engensis at the NYAS Advances in Pain Meeting on May 3, 2022.

IDEAYA Biosciences, Inc. announced that the U.S. Food and Drug Administration has granted orphan-drug designation to darovasertib, a potential first-in-class protein kinase C inhibitor, for the treatment of uveal melanoma.

Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced that the Company will host an Analyst & Investor Day on Friday, May 20, 2022 in New York City.

Bright Minds Biosciences today announced the formation of its Scientific Advisory Board (“SAB”).

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced the promotion of Christine D. Baker to Chief Operating Officer effective immediately.

Gritstone bio, Inc. announced that it will report its financial results for the first quarter ended March 31, 2022 and provide recent clinical and corporate updates via a press release on Thursday, May 5, 2022 at 4:05pm Eastern Time.

HilleVax, Inc. (Nasdaq: HLVX), a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates, reported today dosing of the first subjects in its previously announced Phase 2b clinical trial of HIL-214, the company’s virus-like particle (VLP) based vaccine candidate, for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection in infants.